Access Marketing Lead

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision:
We aspire to cure cancer. Here, you ll build a career grounded in purpose and be empowered to deliver your best.

As the Access Marketing Lead, you will lead Patient Value & Access (PVA) strategic and tactical planning for a successful upcoming launch delivering optimal patient access and reimbursement while managing gross-to-nets to maximize asset value. You will coordinate and align PVA functions and work streams to ensure launch readiness, integrated strategic and tactical planning, and impactful execution to achieve brand objectives and KPIs.

You will also collaborate across the US and Global Oncology BU including Marketing, Sales, HEOR, Global Value and Access, and Medical reinforcing a One Oncology Takeda approach.

• You will ensure deep Oncology ecosystem insights, understanding, and customer potential barriers and drive value demonstration to support patient access across key stakeholders including Payers, Strategic Accounts, and GPOs along with other critical intermediaries and influencers (e.g., NCCN, etc)
• Develop robust launch tactical resources and tools (personal and non-personal) that support the field organizations, including pull-through and patient support, to realize and measure launch goals, objectives and KPIs
• Lead development and alignment of an integrated PVA launch strategy, tactical plan, and budget/resource management together with the Integrated Brand team; represent PVA in brand, global, and cross-functional activities ensuring tight communication with PVA leadership, alignment of strategy and execution plans, and identify opportunities for synergies.
• Responsible to develop a focused and impactful plan to generate optimal coding, coverage, and reimbursement for upcoming launch across Payers and Oncology stakeholders including GPOs and strategic accounts, as well as other entities (e.g., VA/DoD, potential ICER risk management/preparation, etc.
• Generate deep, actionable, and impactful market and customer insights through leading market research and analytics exercises to ensure critical understanding of drivers/barriers and opportunities/threats
• Support and contribute to launch sales and GtN forecast, build bottoms up coverage forecast, and partner with PVA teams on contracting strategy and scenario planning for GPO and Payers (across segments and channels)
• Develop impactful tools, resources, and materials for clarity on coding, support coverage and value demonstration (e.g., PIE, Payer and Strategic Account Value Proposition), and reimbursement with focus on field teams includes sales support and pull-through
• Partner to identify and develop critical capabilities needed for a successful launch as the Oncology market continues to be dynamic with shift in needs to ensure success
• Support reach to PVA customers by partnering with field teams leads to develop innovative and creative ways reach access to decision-makers, stakeholders, and influencers (e.g., non-personal and digital programing)
• Accountable for robust project management keeping PVA team on cadence with brand timelines, set clear timelines and milestones for PVA, and manage budget/resources in concert with the PVA leadership team.
• Identify additional and emerging opportunities and levers to drive access and mitigate threats, challenges and hurdles to patients receiving access to therapy.

• Bachelor’s degree in a related field required;
  Advanced degree preferred (MBA/MPH/Pharm
  
  D/PhD)
• 9+ years of pharmaceutical industry experience required with a strong track record of success including launch experience in complex and competitive therapeutic areas (i.e., multiple MOAs, unique patient journey, generics/biosimilars, shifting…